Physicians’ Education Resource® Presents “Cutting CVD Risk by Adding PCSK9 Inhibitors: What the Internist Needs to Know”

March 25, 2019 Off By BusinessWire

This live symposium will be held adjunct to the 2019 American College
of Physicians Internal Medicine Meeting

CRANBURY, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CME?src=hash" target="_blank"gt;#CMElt;/agt;–Physicians’ Education Resource® (PER®), a worldwide leader in continuing
medical education (CME), will conduct a live CME-accredited activity,
“Cutting CVD Risk by Adding PCSK9 Inhibitors: What the Internist Needs
to Know,” as a satellite symposium adjunct to the 2019 American College
of Physicians Internal Medicine Meeting. The symposium will take place
Wednesday, April 10, from 7 to 9 p.m. at the Philadelphia Marriott
Downtown and will be chaired by James A. Underberg, M.D., M.S.,
FACPM, FACP, FNYAM, FASPC, FNLA
, clinical assistant professor of
medicine, NYU School of Medicine & NYU Center for Prevention of
Cardiovascular Disease and director, Bellevue Hospital Lipid Clinic.

“Although many doctors prescribe statins to help lower cholesterol
levels in patients, a large portion of these patients remain at residual
cardiovascular disease risk,” said Phil Talamo, president of PER®. “This
program will explore the latest cholesterol-lowering national guidelines
and evidence for non-statin options for patients who are not reaching
lipid-lowering goals.”

In this engaging, interactive, case-based symposium, a panel of renowned
experts in dyslipidemia management will review the latest clinical trial
data on PCSK9 inhibitors and provide insights into the most challenging
lipid-lowering scenarios for managing patients with CVD. Those who
attend this symposium will hear expert interpretation of the latest
cholesterol-lowering guidelines, receive guidance on issues of statin
intolerance and severe hypercholesterolemia, learn evidence-based
strategies for management of dyslipidemia with non-statin therapies, and
be updated on indications for PCSK9 inhibitors and real-world
experience, as well as have an opportunity to network with peers.

This live activity is accredited by the Accreditation Council for
Continuing Medical Education for 2.0 AMA PRA Category 1 Credits™ for
physicians. For more information and to register, click here.

About Physicians’ Education Resource® (PER®)

Since 1995, PER® has been dedicated to advancing cancer care
through professional education and now furthers patient care and
treatment strategies on a wide variety of chronic illnesses and
diseases. In 2016, PER® initiated continuing medical
education (CME) programming in the cardiovascular and endocrinology
areas. While continuing to expand into topics outside of oncology, PER®
remains the leading provider of live, online and print CME activities
related to oncology and hematology. The high-quality, evidence-based
activities feature leading distinguished experts who focus on the
application of practice-changing advances. PER® is accredited
by the Accreditation Council for Continuing Medical Education and the
California Board of Registered Nursing. PER® is part of the
Cranbury, New Jersey-based MJH Associates, Inc., family of businesses.
Learn more at http://www.gotoper.com
and http://www.mjhassoc.com.

Contacts

PER® Media Contacts
Alexandra Ventura, 609-716-7777,
ext. 121
[email protected]

John
Patricolo, 609-325-4630
[email protected]